FSB Premier Wealth Management’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-3,957
Closed -$249K 209
2024
Q3
$249K Buy
3,957
+401
+11% +$23.4K 0.1% 181
2024
Q2
$210K Buy
+3,556
New +$222K 0.09% 173
2023
Q1
Sell
-3,083
Closed -$287K 148
2022
Q4
$287K Buy
3,083
+1
+0% +$96 0.16% 116
2022
Q3
$293K Buy
3,082
+11
+0.4% +$1.09K 0.17% 110
2022
Q2
$284K Sell
3,071
-13
-0.4% -$1.27K 0.16% 113
2022
Q1
$311K Sell
3,084
-174
-5% -$18.3K 0.16% 111
2021
Q4
$336K Buy
3,258
+491
+18% +$45.4K 0.14% 105
2021
Q3
$234K Buy
2,767
+52
+2% +$4.36K 0.12% 98
2021
Q2
$226K Buy
2,715
+26
+1% +$2.13K 0.12% 93
2021
Q1
$202K Sell
2,689
-680
-20% -$49.5K 0.11% 96
2020
Q4
$230K Buy
+3,369
New +$219K 0.12% 92

Other funds holding CVS

FSB Premier Wealth Management's CVS Position: Q4 2024 in Review

FSB Premier Wealth Management sold out of CVS Health (CVS) in Q4 2024, closing a stake of 3,957 shares — an estimated $249K sold.

FSB Premier Wealth Management first reported a position in CVS in Q4 2020 and held it in 11 quarters. The position peaked at $336K in Q4 2021. 1,668 funds tracked by Wall St. Rank hold CVS as of Q4 2024.

  • FSB Premier Wealth Management reported no remaining CVS Health position as of Q4 2024 after selling out during the quarter.
  • FSB Premier Wealth Management sold 3,957 CVS Health shares in Q4 2024, an estimated $249K.
  • FSB Premier Wealth Management first reported a position in CVS Health in Q4 2020 and held it in 11 quarters.
  • FSB Premier Wealth Management's CVS Health position peaked at $336K in Q4 2021.
  • 1,668 funds tracked by Wall St. Rank held CVS Health as of Q4 2024.

Based on FSB Premier Wealth Management's 13F filing for Q4 2024, filed 12 Feb 2025.